ROMOSOZUMAB AND DENOSUMAB COMBINATION THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
Adami, G. [1 ]
Fassio, A. [1 ]
Gatti, D. [1 ]
Viapiana, O. [1 ]
Benini, C. [1 ]
Rossini, M. [1 ]
机构：
[1] Univ Verona, Rheumatol Unit, Verona, Italy
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2024年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P504
引用
收藏
页码：S268 / S269
页数：2
相关论文
共 50 条
  • [1] ROMOSOZUMAB AND DENOSUMAB COMBINATION THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS
    Adami, G.
    Fassio, A.
    Gatti, D.
    Viapiana, O.
    Benini, C.
    Rossini, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S28 - S29
  • [2] Denosumab versus romosozumab for postmenopausal osteoporosis treatment
    Kobayakawa, Tomonori
    Miyazaki, Akiko
    Saito, Makoto
    Suzuki, Takako
    Takahashi, Jun
    Nakamura, Yukio
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Denosumab versus romosozumab for postmenopausal osteoporosis treatment
    Tomonori Kobayakawa
    Akiko Miyazaki
    Makoto Saito
    Takako Suzuki
    Jun Takahashi
    Yukio Nakamura
    Scientific Reports, 11
  • [4] Romosozumab and denosumab combination therapy in post-menopausal osteoporosis
    Adami, Giovanni
    Viapiana, Ombretta
    Fassio, Angelo
    Gatti, Davide
    Rossini, Maurizio
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 50 - 50
  • [5] Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study
    Adami, Giovanni
    Pedrollo, Elisa
    Rossini, Maurizio
    Fassio, Angelo
    Braga, Vania
    Pasetto, Emma
    Pollastri, Francesco
    Benini, Camilla
    Viapiana, Ombretta
    Gatti, Davide
    JBMR PLUS, 2024, 8 (04)
  • [6] Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis
    K. Ebina
    Y. Etani
    H. Tsuboi
    Y. Nagayama
    M. Kashii
    A. Miyama
    Y. Kunugiza
    M. Hirao
    G. Okamura
    T. Noguchi
    K. Takami
    A. Goshima
    T. Miura
    Y. Fukuda
    T. Kurihara
    S. Okada
    K. Nakata
    Osteoporosis International, 2022, 33 : 1807 - 1813
  • [7] Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis
    Ebina, K.
    Etani, Y.
    Tsuboi, H.
    Nagayama, Y.
    Kashii, M.
    Miyama, A.
    Kunugiza, Y.
    Hirao, M.
    Okamura, G.
    Noguchi, T.
    Takami, K.
    Goshima, A.
    Miura, T.
    Fukuda, Y.
    Kurihara, T.
    Okada, S.
    Nakata, K.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (08) : 1807 - 1813
  • [8] Comparative effectiveness of romosozumab to denosumab in the treatment of osteoporosis in postmenopausal women: A systematic review
    Anina, Daniele
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 627 - 627
  • [9] Romosozumab is associated with greater trabecular score improvement compared to denosumab in postmenopausal osteoporosis
    Shin, Sungjae
    Rhee, Yumie
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 166 - 166
  • [10] Combination therapy Denosumab and Alfacalcidol in Postmenopausal Osteoporosis - tree years experience.
    Galesanu, Corina
    Loghin, Andra Iulia
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S475 - S475
12345